News
Novo Nordisk has launched its weight-loss drug Wegovy in India, while Eli Lilly's Mounjaro has received regulatory approval, ...
19hon MSN
With Novo Nordisk’s Wegovy already in the market, Eli Lilly is stepping up its game with a patient-friendly pen device, ...
Eli Lilly will soon launch Mounjaro KwikPen in India. This follows regulatory approval for the diabetes and obesity drug. The ...
1h
Zacks.com on MSNNVO vs. LLY: Which Obesity Powerhouse is the Stronger Bet Now?Eli Lilly edges ahead of Novo Nordisk as the stronger obesity bet, backed by robust sales growth, pipeline depth and ...
(Reuters) -India’s drug regulator on Thursday approved the launch of pre-filled injector pens of Eli Lilly (NYSE: LLY )’s ...
Mounjaro users in the UK have to jump through quite a few hoops to get their hands on the weight-loss drug. You might think ...
29m
inews.co.uk on MSNGPs swamped by requests for NHS Mounjaro – but hardly anyone qualifiesThousands taking Mounjaro privately are inundating GP surgeries - clogging phone lines, exacerbating the 8am scramble for ...
Eli Lillys Mounjaro KwikPen gains approval in India, targeting diabetes and obesity with its dual-action formula for weight ...
1h
The i Paper on MSNGPs swamped by requests for NHS Mounjaro - but no one qualifiesThousands taking Mounjaro privately are inundating GP surgeries - clogging phone lines, exacerbating the 8am scramble for ...
15h
Health and Me on MSNEli Lilly’s Mounjaro Kwikpen Gets Indian Approval For Diabetes And Weight LossEli Lilly announced that its breakthrough drug, Mounjaro (tirzepatide), has received marketing authorization from India’s ...
9hon MSN
Exclusive: Julie Bishop lost two-and-a-half stone in eight weeks by taking Mounjaro before she was sent to hospital with ...
14h
Stocktwits on MSNGLP-1 Showdown In India: Eli Lilly’s Mounjaro Pen Approved Just Days After Novo’s Wegovy LaunchIndia’s health regulator has approved Eli Lilly’s pre-filled pen version of Mounjaro, expanding its availability across six ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results